Drug Approval | March 19, 2023
Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit
The observations are procedural in nature
The observations are procedural in nature
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Expands robotics to 20+ specialities
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
A funding to expand operations and provide better patient care
Subscribe To Our Newsletter & Stay Updated
